Company Analysis Elanco Animal Health
1. Summary
Advantages
- Price (10.33 $) is less than fair price (14.53 $)
- The company's current efficiency (ROE=-19.78%) is higher than the sector average (ROE=-82.41%)
Disadvantages
- Dividends (0%) are below the sector average (1.31%).
- The stock's return over the last year (-35.1%) is lower than the sector average (-18.38%).
- Current debt level 40.2% has increased over 5 years from 26.25%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Elanco Animal Health | Healthcare | Index | |
|---|---|---|---|
| 7 days | -4.7% | -13.3% | 2.7% |
| 90 days | -18% | -13% | -4.5% |
| 1 year | -35.1% | -18.4% | 10% |
ELAN vs Sector: Elanco Animal Health has significantly underperformed the "Healthcare" sector by -16.72% over the past year.
ELAN vs Market: Elanco Animal Health has significantly underperformed the market by -45.15% over the past year.
Stable price: ELAN is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ELAN with weekly volatility of -0.6751% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (10.33 $) is lower than the fair price (14.53 $).
Price significantly below the fair price: The current price (10.33 $) is 40.7% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (114.26).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (73.05).
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.17) is lower than that of the sector as a whole (9.02).
P/BV vs Market: The company's P/BV (1.17) is lower than that of the market as a whole (22.32).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.65) is lower than that of the sector as a whole (4.1).
P/S vs Market: The company's P/S indicator (1.65) is lower than that of the market as a whole (15.91).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (13.44) is lower than that of the sector as a whole (17.72).
EV/Ebitda vs Market: The company's EV/Ebitda (13.44) is lower than that of the market as a whole (23.05).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 23.96% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (23.96%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-50.52%).
5.4. ROE
ROE vs Sector: The company's ROE (-19.78%) is higher than that of the sector as a whole (-82.41%).
ROE vs Market: The company's ROE (-19.78%) is lower than that of the market as a whole (25.12%).
5.5. ROA
ROA vs Sector: The company's ROA (-8.57%) is lower than that of the sector as a whole (6.75%).
ROA vs Market: The company's ROA (-8.57%) is lower than that of the market as a whole (6.65%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-1.18%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (-1.18%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.31%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
